Home » Topics » Disease categories and therapies » Dental

Dental
RSS

Selective Lys-gingipain inhibitors for use in periodontitis

July 3, 2002

Periostat receives final marketing approvals in Portugal and The Netherlands

July 2, 2002

Platelet-derived growth factor evaluated in periodontal disease

May 31, 2002

Periostat approved in Israel

May 8, 2002

Periostat approved in Austria and Finland

April 26, 2002

MMP inhibitors with activity in animal model of periodontitis

April 2, 2002

Bakuchiol has in vitro antimicrobial activity against oral pathogens

Dec. 17, 2001

Positive data presented for OC-1016, a novel bone- and tissue-regenerating agent

Oct. 10, 2001

CollaGenex to market dental products from Atrix in the U.S.

Aug. 30, 2001

Graft material for oral mucosal defects

Aug. 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 14, 2025.
Circode applies circRNA to heart disease drug R&D, in vivo CAR T
BioWorld
Shanghai Circode Biomed Co. Ltd. is set to begin clinical trials of HM-2002, a circular RNA (circRNA)-based drug for ischemic heart disease, having gained IND...
BD’s biosciences & diagnostics unit in $17.5B merger with Waters
BioWorld MedTech
Three months earlier than an expected update on a deal, Becton, Dickinson and Co. reported its biosciences and diagnostic solutions business will combine with...
Incurix describes new c-Myc inhibitors
BioWorld Science
Incurix Co. Ltd. has identified Myc proto-oncogene protein (c-Myc) inhibitors reported to be useful for the treatment of cancer.